Search -

Displaying 1 - 20 of 24

Sort: Relevancy | Date

Presentation TCT 2016

Very Long Term Outcomes after FFR-Based Decision-Making

Presenter: Nick Curzen, Nils Johnson, Frederik M. Zimmermann

November 01, 2016

Presentation TCT 2016

iFR in Acute Coronary Syndromes

Presenter: Nick Curzen, Nils Johnson, Justin E. Davies

November 01, 2016

Presentation TCT 2016

FFR in ACS: Current Data Including DOCTORS and Upcoming Studies

Presenter: Nick Curzen, Nils Johnson, Thomas Engstroem

November 01, 2016

Presentation TCT 2016

FFR in ACS: Specifics and Timing of Measurements

Presenter: Nick Curzen, Nils Johnson, Habib Samady

November 01, 2016

Presentation TCT 2016

Contrast as a Hyperemic Agent: Easier, but Sufficient?

Presenter: Allen Jeremias, Nico H.J. Pijls, Nils Johnson

October 31, 2016

Presentation Stanford Coronary Physiology Conference 2016

Adenosine-free Indices: Resting Pd/Pa, iFR, and cFFR

Presenter: Nils P. Johnson

October 28, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR in... Bifucation Disease

Presenter: Nils P. Johnson

October 28, 2016

Presentation TCT 2015

Novel Hyperemic Agents (Regadenoson, Nicorandil, and Nitroprusside)

Presenter: Allen Jeremias, Nils Johnson, Habib Samady

October 12, 2015

Presentation TCT 2015

Left Main Disease: When to Use FFR vs IVUS

Presenter: Allen Jeremias, Nils Johnson, William F. Fearon

October 12, 2015

Presentation TCT 2015

Intracoronary Physiology in NSTEMI and STEMI: Is Accurate Lesion Assessment Possible?

Presenter: Allen Jeremias, Nils Johnson, Colin Berry

October 12, 2015

Presentation TCT 2015

Fifteen-Year DEFER and 5-Year FAME Outcomes

Presenter: Allen Jeremias, Nils Johnson, Nico H.J. Pijls

October 12, 2015

Presentation TCT 2015

The Ischemic Continuum: What Is the Significance of a Lower FFR?

Presenter: Justin E. Davies, Bernard De Bruyne, Nils Johnson

October 12, 2015

Presentation

Prognostic Value of FFR: Linking PhysiologicSeverity to Clinical Outcomes

Presenter: Nils P. Johnson

October 16, 2014

Presentation TCT 2014

Role of Intravascular Imaging in NSTE-ACS and STEMI

Presenter: Nils Johnson, Bernhard Witzenbichler, Michel R. Le May, Fernando Alfonso

September 16, 2014

Presentation TCT 2014

Role of FFR, IMR, and Other Physiologic Measures in NSTE-ACS and STEMI

Presenter: Nils Johnson, Bernhard Witzenbichler, Michel R. Le May, Colin Berry

September 16, 2014

Presentation Physiology and Intravascular Imaging 2014

PRO: Hyperemia Adds Significantly to Detection of Ischemia and Is Essential for Accurate Physiological Lesion Assessment

Presenter: Nils P. Johnson

March 28, 2014

Presentation Physiology and Intravascular Imaging 2014

Case Studies: FFR Artifacts

Presenter: Nils P. Johnson

March 27, 2014

Presentation TCT 2013

What's the Difference Between Hyperemic (FFR) and Resting Indices (Pd/Pa, iFR)?

Presenter: Nils Johnson

October 31, 2013

Presentation TCT 2013

Can Basal Modalities Ever Be as Good as Hyperemic Indices?

Presenter: Nils Johnson

October 31, 2013

Presentation TCT 2013

PET and Fusion PET-CT: Potential Role for Metabolic Imaging of Vulnerable Plaque

Presenter: Nils Johnson

October 30, 2013

Advertisement

Very Long Term Outcomes after FFR-Based Decision-Making

iFR in Acute Coronary Syndromes

FFR in ACS: Current Data Including DOCTORS and Upcoming Studies

FFR in ACS: Specifics and Timing of Measurements

Contrast as a Hyperemic Agent: Easier, but Sufficient?

Adenosine-free Indices: Resting Pd/Pa, iFR, and cFFR

FFR in... Bifucation Disease

Novel Hyperemic Agents (Regadenoson, Nicorandil, and Nitroprusside)

Left Main Disease: When to Use FFR vs IVUS

Intracoronary Physiology in NSTEMI and STEMI: Is Accurate Lesion Assessment Possible?

Fifteen-Year DEFER and 5-Year FAME Outcomes

The Ischemic Continuum: What Is the Significance of a Lower FFR?

Prognostic Value of FFR: Linking PhysiologicSeverity to Clinical Outcomes

Role of Intravascular Imaging in NSTE-ACS and STEMI

Role of FFR, IMR, and Other Physiologic Measures in NSTE-ACS and STEMI

PRO: Hyperemia Adds Significantly to Detection of Ischemia and Is Essential for Accurate Physiological Lesion Assessment

Case Studies: FFR Artifacts

What's the Difference Between Hyperemic (FFR) and Resting Indices (Pd/Pa, iFR)?

Can Basal Modalities Ever Be as Good as Hyperemic Indices?

PET and Fusion PET-CT: Potential Role for Metabolic Imaging of Vulnerable Plaque

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content